Source: Annual Congress 2012 - New results in molecular pathology and functional genomics of neoplastic and non-neoplastic lung disease
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
V. Mineev, L. Sorokina, M. Nyoma, G. Lipkin, V. Lim, A. Eremeeva, Y. Malfygina, V. Ivanov, V. Trofimov (Saint-Petersburg, Russian Federation). The role of transcription factor PAX-5 (BSAP) in asthma severity and in the activity of allergic inflammation. Eur Respir J 2012; 40: Suppl. 56, 779

Member's Comments

No comment yet.

Related content which might interest you: Protective effect of transcription factor PAX-5 (BSAP) on asthma severity Source: Annual Congress 2011 - New mechanisms in airway disease Year: 2011 Transcription factor GATA-3 as a specific marker of allergic bronchial asthma Source: Annual Congress 2010 - Asthma: clinical aspects and treatment Year: 2010 New aspects of the action of IL-4 on the activity of the transcription factor STAT6 in allergic and non-allergic asthma Source: Annual Congress 2009 - Inflammatory cells and cytokines Year: 2009 GATA-3 or T-bet: Who is the crucial marker of allergic bronchial asthma Source: Annual Congress 2011 - New mechanisms in airway disease Year: 2011 Increased expression of lymphocyte transcription factor T-bet in COPD Source: Annual Congress 2009 - COPD: basic science and clinical studies Year: 2009 Egr-1 regulates muc5ac expression through activator protein-1 (AP-1) in chronic airway inflammation diseases Source: International Congress 2015 – Translational studies in airway cell biology Year: 2015 Asthma and diabetes: Possible markers of their co-existence. The possible role of transcription factors GATA-3 and T-bet and negative regulator of transcription SOCS1 in the worsening of asthma Source: International Congress 2015 – Translational research in respiratory care: new findings Year: 2015 Allergic inflammatory cells use different GATA factors to activate CCR3 transcription Source: Annual Congress 2012 - Asthma: mechanisms of airway inflammation Year: 2012 TNFAIP3/A20 expression in allergic asthma Source: International Congress 2019 – Identification of new targets and therapeutic strategies for lung disease Year: 2019 Expression of GATA family of transcription factors in T-cells, monocytes and bronchial biopsies Source: Eur Respir J 2001; 18: 466-473 Year: 2001 The asthma-like phenotype in VIP-/- mice may be related to activation of transcription factor NFAT Source: Annual Congress 2008 - Cell biology of asthma and COPD Year: 2008 A decreased expression of leptin receptor may contribute to the pathogenesis of the allergic rhinitis Source: Annual Congress 2010 - Asthma: clinical aspects and treatment Year: 2010 Transcriptional factors F???3, ?-Maf, GATA3 and T-bet in different variants of bronchial asthma Source: International Congress 2017 – Gene signatures in bronchial diseases Year: 2017 Overexpression of suppressor of cytokine signaling-5 augments eosinophilic inflammation in an asthma model Source: Eur Respir J 2004; 24: Suppl. 48, 348s Year: 2004 Gene polymorphism of epidermal growth factor receptor (EGFR) and airway hyperresponsiveness (AHR) in young allergic subjects without respiratory symptoms Source: Annual Congress 2011 - Biomarkers of allergic inflammation Year: 2011 ILC2 cells from severe allergic and eosinophilic asthma demonstrate increased expression of TSLP receptor (TSLPR) and enhanced proliferative capacity. Source: Virtual Congress 2021 – New insight into the immunology of allergies, asthma and COPD: from mouse to man Year: 2021 The basic helix-loop-helix transcription factor scleraxis (Scx) is overexpressed in systemic and lung fibrosing diseases Source: International Congress 2017 – The spectrum of CTDs: from pathogenesis to treatment Year: 2017 Reduced expression of the transcription factor KLF4 in COPD macrophages is associated with dysfunctional differentiation Source: International Congress 2017 – Translational studies of lung disease Year: 2017 Selective decoy-mediated inhibition of activator protein-1 activity in the airways prevents experimental asthmatic inflammation Source: Annual Congress 2005 - Regulation of the allergic and asthmatic response Year: 2005